Browsing by Author "Djarmati, A. (6508159253)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication MECP2 mutations in Serbian Rett syndrome patients(2007) ;Djarmati, A. (6508159253) ;Dobričić, V. (22952783800) ;Kecmanović, M. (36860979600) ;Marsh, P. (7103227169) ;Jančić-Stefanović, J. (54886827500) ;Klein, C. (26642933500) ;Djurić, M. (59844633900)Romac, S. (7003983993)Background - Rett syndrome is a severe neurodevelopmental X-linked dominant disorder affecting 1/15,000 girls worldwide. Eight years ago, the MECP2 gene was associated with the devastating clinical features observed in Rett syndrome patients. Objectives - To investigate the spectrum and the frequency of MECP2 mutations in Serbian Rett syndrome patients. Patients and methods - We screened the MECP2 coding region by conventional mutational screening (single-strand conformation polymorphism/sequencing) in 24 patients of Serbian origin and in their 41 unaffected family members. In search for gene dosage alterations in seemingly mutation-negative girls, we developed a new, specific quantitative PCR method. Results - Nineteen patients (79%) carried MECP2 mutations, five of which were novel (one nonsense mutation, one duplication and three deletions). Fourteen previously described disease-causing sequence changes and one polymorphism were also detected. Detailed case reports are given for the carriers of the novel mutations. Large MECP2 rearrangements cause Rett syndrome in a significant number of girls without 'classic' mutations in this gene. Therefore, we developed a specific quantitative PCR method, covering MECP2 exons 3 and 4, which previously has not been used for screening. No dosage alterations of the two exons were found in the four tested mutation-negative girls. Conclusions - This is the first genetic study of Rett syndrome in Serbian patients describing the MECP2 mutational and phenotypic spectrum in this population. Detailed clinical descriptions of this ethnically homogeneous patient population add to our knowledge of genotype/phenotype correlations in this severe condition. © 2007 The Authors. - Some of the metrics are blocked by yourconsent settings
Publication MECP2 mutations in Serbian Rett syndrome patients(2007) ;Djarmati, A. (6508159253) ;Dobričić, V. (22952783800) ;Kecmanović, M. (36860979600) ;Marsh, P. (7103227169) ;Jančić-Stefanović, J. (54886827500) ;Klein, C. (26642933500) ;Djurić, M. (59844633900)Romac, S. (7003983993)Background - Rett syndrome is a severe neurodevelopmental X-linked dominant disorder affecting 1/15,000 girls worldwide. Eight years ago, the MECP2 gene was associated with the devastating clinical features observed in Rett syndrome patients. Objectives - To investigate the spectrum and the frequency of MECP2 mutations in Serbian Rett syndrome patients. Patients and methods - We screened the MECP2 coding region by conventional mutational screening (single-strand conformation polymorphism/sequencing) in 24 patients of Serbian origin and in their 41 unaffected family members. In search for gene dosage alterations in seemingly mutation-negative girls, we developed a new, specific quantitative PCR method. Results - Nineteen patients (79%) carried MECP2 mutations, five of which were novel (one nonsense mutation, one duplication and three deletions). Fourteen previously described disease-causing sequence changes and one polymorphism were also detected. Detailed case reports are given for the carriers of the novel mutations. Large MECP2 rearrangements cause Rett syndrome in a significant number of girls without 'classic' mutations in this gene. Therefore, we developed a specific quantitative PCR method, covering MECP2 exons 3 and 4, which previously has not been used for screening. No dosage alterations of the two exons were found in the four tested mutation-negative girls. Conclusions - This is the first genetic study of Rett syndrome in Serbian patients describing the MECP2 mutational and phenotypic spectrum in this population. Detailed clinical descriptions of this ethnically homogeneous patient population add to our knowledge of genotype/phenotype correlations in this severe condition. © 2007 The Authors. - Some of the metrics are blocked by yourconsent settings
Publication Spinocerebellar ataxia type 17 in the Yugoslav population(2004) ;Alendar, A. (58223228800) ;Čuljković, B. (37033675400) ;Savić, D. (18435454500) ;Djarmati, A. (6508159253) ;Keckarević, M. (18434375900) ;Ristić, A. (7003835405) ;Dragašević, N. (59157743200) ;Kosić, V. (57199335827)Romac, S. (7003983993)Objectives - (1) Analysis of Spinocerebellar ataxia type 17 (SCA17) locus in a group of ataxic patients excluded on other known SCAs; (2) assessment of frequency distributions of SCA17 alleles in the Yugoslav population. Material and methods - Study includes 115 non-related Yugoslav patients belonging to autosomal-dominant cerebellar ataxias or to sporadic idiopathic adult-onset ataxia and 115 controls. Analysis of SCA17 locus was performed using polymerase chain reaction. Results - None of the analyzed patients show the presence of mutation in SCA17 locus. In the group of patients 12 different alleles in the range of 30-42 repeats were observed, while in healthy population eight alleles in the range of 30-40 repeats were detected. Conclusion -(1) None of 115 non-related Yugoslav ataxic patients belong to any known SCAs nor to DRPLA gene; (2) the distribution of SCA17 alleles in the Yugoslav population is consistent with the distribution in other populations and (3) the paucity of alleles with more than 39 repeats could suggest that SCA17 is very rare in the Yugoslav population. - Some of the metrics are blocked by yourconsent settings
Publication Spinocerebellar ataxia type 17 in the Yugoslav population(2004) ;Alendar, A. (58223228800) ;Čuljković, B. (37033675400) ;Savić, D. (18435454500) ;Djarmati, A. (6508159253) ;Keckarević, M. (18434375900) ;Ristić, A. (7003835405) ;Dragašević, N. (59157743200) ;Kosić, V. (57199335827)Romac, S. (7003983993)Objectives - (1) Analysis of Spinocerebellar ataxia type 17 (SCA17) locus in a group of ataxic patients excluded on other known SCAs; (2) assessment of frequency distributions of SCA17 alleles in the Yugoslav population. Material and methods - Study includes 115 non-related Yugoslav patients belonging to autosomal-dominant cerebellar ataxias or to sporadic idiopathic adult-onset ataxia and 115 controls. Analysis of SCA17 locus was performed using polymerase chain reaction. Results - None of the analyzed patients show the presence of mutation in SCA17 locus. In the group of patients 12 different alleles in the range of 30-42 repeats were observed, while in healthy population eight alleles in the range of 30-40 repeats were detected. Conclusion -(1) None of 115 non-related Yugoslav ataxic patients belong to any known SCAs nor to DRPLA gene; (2) the distribution of SCA17 alleles in the Yugoslav population is consistent with the distribution in other populations and (3) the paucity of alleles with more than 39 repeats could suggest that SCA17 is very rare in the Yugoslav population.
